Literature DB >> 30587447

Analysis of chain length, substitution patterns, and unsaturation of AM-404 derivatives as 20S proteasome stimulators.

Rachel A Coleman1, Christine S Muli1, Yizhou Zhao2, Atul Bhardwaj1, Timothy R Newhouse2, Darci J Trader3.   

Abstract

Proteasome-mediated degradation of proteins is a vital cellular process and is performed by the ubiquitin-dependent proteasome system (UPS) and the ubiquitin-independent proteasome system (UIPS). While both systems are necessary to maintain healthy cell function, many disease states are characterized by reduced activity of the UPS, and the UIPS cannot by itself maintain proper protein levels. It has been suggested that the 20S core particle (20S CP), the isoform of the proteasome in the UIPS that can degrade proteins without a ubiquitin tag, can be stimulated with a small molecule to assist the 20S CP to accept and hydrolyze substrates more rapidly. Several small molecule stimulators of the 20S CP have since been discovered, including AM-404, an arachidonic acid derivative. AM-404 has previously been shown to inhibit fatty acid amide hydrolase activity. We wished to evaluate what structural components of AM-404 are required to stimulate the 20S CP with the long-term goal of using this information to design a stimulator with better drug-like qualities. We synthesized numerous derivatives of AM-404, varying the chain length, substitutions, and degree of unsaturation. Through this endeavor, we obtained several molecules capable of stimulating the 20S CP to various degrees. We discovered that though chain length is important, the presence of a cis-alkene in a specific location in the aliphatic chain has the greatest impact on the ability to stimulate the 20S CP. Two of the derivatives maintain modest stimulatory activity, and have improved toxicity over AM-404.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AM-404; Proteasome; Stimulator; Synthesis

Mesh:

Substances:

Year:  2018        PMID: 30587447      PMCID: PMC6348054          DOI: 10.1016/j.bmcl.2018.12.030

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  Proteasomal function is impaired in substantia nigra in Parkinson's disease.

Authors:  K S McNaught; P Jenner
Journal:  Neurosci Lett       Date:  2001-01-19       Impact factor: 3.046

2.  Altered proteasome function and subunit composition in aged muscle.

Authors:  Aimee D Husom; Elizabeth A Peters; Erin A Kolling; Nicole A Fugere; LaDora V Thompson; Deborah A Ferrington
Journal:  Arch Biochem Biophys       Date:  2004-01-01       Impact factor: 4.013

Review 3.  Protein degradation by the ubiquitin-proteasome pathway in normal and disease states.

Authors:  Stewart H Lecker; Alfred L Goldberg; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

4.  Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.

Authors:  Corey L Jones; Evert Njomen; Benita Sjögren; Thomas S Dexheimer; Jetze J Tepe
Journal:  ACS Chem Biol       Date:  2017-08-01       Impact factor: 5.100

Review 5.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

6.  Allyl-Palladium-Catalyzed α,β-Dehydrogenation of Carboxylic Acids via Enediolates.

Authors:  Yizhou Zhao; Yifeng Chen; Timothy R Newhouse
Journal:  Angew Chem Int Ed Engl       Date:  2017-09-06       Impact factor: 15.336

Review 7.  Protein Oxidation in Aging: Does It Play a Role in Aging Progression?

Authors:  Sandra Reeg; Tilman Grune
Journal:  Antioxid Redox Signal       Date:  2014-10-09       Impact factor: 8.401

Review 8.  Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.

Authors:  Kwadwo A Opoku-Nsiah; Jason E Gestwicki
Journal:  Transl Res       Date:  2018-06-19       Impact factor: 7.012

9.  Crystal structure of a low molecular weight activator Blm-pep with yeast 20S proteasome - insights into the enzyme activation mechanism.

Authors:  Julia Witkowska; Małgorzata Giżyńska; Przemysław Grudnik; Przemysław Golik; Przemysław Karpowicz; Artur Giełdoń; Grzegorz Dubin; Elżbieta Jankowska
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

10.  AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity.

Authors:  Soraya Wilke Saliba; Ariel R Marcotegui; Ellen Fortwängler; Johannes Ditrich; Juan Carlos Perazzo; Eduardo Muñoz; Antônio Carlos Pinheiro de Oliveira; Bernd L Fiebich
Journal:  J Neuroinflammation       Date:  2017-12-13       Impact factor: 8.322

View more
  7 in total

Review 1.  Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.

Authors:  Evert Njomen; Jetze J Tepe
Journal:  J Med Chem       Date:  2019-03-14       Impact factor: 7.446

2.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

3.  Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma.

Authors:  Evert Njomen; Allison Vanecek; Theresa A Lansdell; Ya-Ting Yang; Peter Z Schall; Christi M Harris; Matthew P Bernard; Daniel Isaac; Omar Alkharabsheh; Anas Al-Janadi; Matthew B Giletto; Edmund Ellsworth; Catherine Taylor; Terence Tang; Sarah Lau; Marc Bailie; Jamie J Bernard; Vilma Yuzbasiyan-Gurkan; Jetze J Tepe
Journal:  Biomedicines       Date:  2022-04-19

4.  Fluorescent Probes with Unnatural Amino Acids to Monitor Proteasome Activity in Real-Time.

Authors:  Breanna L Zerfas; Rachel A Coleman; Andres F Salazar-Chaparro; Nathaniel J Macatangay; Darci J Trader
Journal:  ACS Chem Biol       Date:  2020-08-26       Impact factor: 5.100

5.  Dihydroquinazolines enhance 20S proteasome activity and induce degradation of α-synuclein, an intrinsically disordered protein associated with neurodegeneration.

Authors:  Taylor J Fiolek; Christina L Magyar; Tyler J Wall; Steven B Davies; Molly V Campbell; Christopher J Savich; Jetze J Tepe; R Adam Mosey
Journal:  Bioorg Med Chem Lett       Date:  2021-01-27       Impact factor: 2.823

6.  New Peptide-Based Pharmacophore Activates 20S Proteasome.

Authors:  Paweł A Osmulski; Przemysław Karpowicz; Elżbieta Jankowska; Jonathan Bohmann; Andrew M Pickering; Maria Gaczyńska
Journal:  Molecules       Date:  2020-03-22       Impact factor: 4.411

Review 7.  Advances in Proteasome Enhancement by Small Molecules.

Authors:  Dare E George; Jetze J Tepe
Journal:  Biomolecules       Date:  2021-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.